Zephyrnet Logo

Tag: Euronext

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

TOKYO, Apr 10, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment...

Top News

ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System | BioSpace

The Company is one of the first brain-computer interface entrants accepted into this program, intended to optimize the commercialization pathway for breakthrough medical technology EINDHOVEN,...

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Strasbourg (France), Tokyo (Japan) and Waltham, Mass, Mar 5, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and...

Our journey to a greener future: DGB Group’s strategic expansion into the French market

In an age where environmental sustainability is not just a preference but a necessity, companies across the globe are stepping up to integrate eco-friendly...

Flutter Entertainment Expands Partnership With PARI MUTUEL URBAIN; Strengthens Presence In UK Market With BetConstruct

Flutter Entertainment, a global gambling and sports wagering firm, is excited to reveal that it has officially extended its existing alliance with PARI MUTUEL...

Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure |...

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION23 January 2024, 07:00 am CET DSMBi rates DSR 2.0 as safe following review of data from non-randomized cohort Data from...

Euronext’s €200 Million Share Repurchase Program

Euronext, a pan-European market infrastructure, has announced the initiation of a share repurchase programme, signaling a strategic move driven by strong cash generation capabilities. The programme, with...

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis | BioSpace

REGULATED INFORMATION – INSIDE INFORMATION Pending FDA approval, alfapump could become the first active implantable medical device in the US for treating liver ascites Ghent,...

The 3 best Casino stocks for the sports betting era

Casino stocks are generally having a decent year in 2023. Two of the largest pure-play exchange traded funds (ETFs) are the VanEck Gaming ETF (NASDAQ:BJK) and the Roundhill...

Cboe FX Outperforms in a Month of Mixed Currency Trading Results

Institutional spot currency trading in November 2023 showed mixed results among major market operators, including Cboe FX, Deutsche Börse's 360T, Euronext FX, and Click 365. For the...

Options to Funds: Saxo Unveils Investment Spectrum

Saxo, a fintech specialist specializing in multi-asset trading and investment, has introduced its funds offering in the United Kingdom. This new feature allows retail investors to engage...

Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 – 30, Chicago, IL, USA

AI Theater Presentation: “Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD” Median’s teams will be at booth #4465, South Hall Level 3, to present the latest...

Fidelity seeks green light for Ethereum ETF, following BlackRock’s filing

Fidelity, an asset management firm overseeing $4.5 trillion in assets, has become the latest firm to seek approval for a spot Ethereum (ETH) exchange-traded...

Latest Intelligence

spot_img
spot_img